The Baker Institute is committed to scientific excellence and our ‘2019 Best of Baker Awards’ recognise outstanding research achievement based on scientific publications. They demonstrate areas where scientific discoveries are likely to have significant impact in health and medical research.
Our focus now is on translating this research to develop new drugs and devices, to inform policy, to develop best-practice prevention and treatment guidelines, and to facilitate education programs for healthcare professionals.
This is how our research is making a difference to the health of Australians, and people around the world.
- An integrative systems genetic analysis of mammalian lipid metabolism (Basic Science)
- Reduction in mortality from implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy patients is dependent on the presence of left ventricular scar (Clinical/Epidemiology)
- Treatment of type 2 diabetes with the designer cytokine IC7Fc (Basic Science)
- Trends in incidence of total or type 2 diabetes: systematic review (Clinical/Epidemiology)
- Activated platelets in the tumor microenvironment for targeting of antibody-drug conjugates to tumors and metastases
- Genomic risk score offers predictive performance comparable to clinical risk factors for ischaemic stroke
- Impaired left atrial strain predicts abnormal exercise haemodynamics in heart failure with preserved ejection fraction
- Left ventricular dysfunction and exercise capacity trajectory: implications for subclinical heart failure staging criteria
- MTR-Viewer: identifying regions within genes under purifying selection
- mCSM-PPI2: predicting the effects of mutations on protein-protein interactions
- Multivariate genome-wide association analysis of a cytokine network reveals variants with widespread immune, haematological and cardiometabolic pleiotropy
- Sex differences in heart failure with preserved ejection fraction pathophysiology: a detailed invasive hemodynamic and echocardiographic analysis